FLT3 and acute myeloid leukemia: Finally, to examine the role of CCL5 in TKI‐resistant AML, we analyzed CCL5 expression by RT–qPCR in blast cells isolated from FLT3‐ITD‐mutated AML patients at baseline and at relapse or at the time of blast persistence.